Une revue indépendante, impliquant plusieurs pays, de l’engagement de la communauté dans l’octroi de subventions et les processus de mise en œuvre

Publications

Une revue indépendante, impliquant plusieurs pays, de l’engagement de la communauté dans l’octroi de subventions et les processus de mise en œuvre

25 avril 2017
Global Fund

Le Département de la communauté, des droits et des questions de genre du Fonds Mondial partage ses constatations, conclusions, et recommandations pour améliorer l’implication significative de la communauté dans le financement du Fonds Mondial. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

This independent review, commissioned by the Community, Rights and Gender (CRG) Department at the Global Fund Secretariat, shares findings, conclusions, and recommendations for enhancing the meaningful engagement of communities in all phases of Global Fund grants, with an emphasis on grant making and grant implementation. The review synthesizes lessons learned and good practices for how communities (see definition below and Figure 1) engage meaningfully, and identifies key principles and strategic actions the Global Fund can take to ensure greater accountability between communities, Country Coordinating Mechanisms, other key stakeholders, and the Global Fund itself.

The Community Rights and Gender Advisory Group (CRG AG), a body that provides advice to the CRG Department, oversaw this independent review, which was carried out by the Community Action and Leadership Collaborative (CLAC), and led by MSMGF (the Global Forum on MSM & HIV). A team of three consultants was responsible for the research, analysis, and writing of this report. Further, preliminary findings and recommendations were validated by way of community consultations in seven countries: Cameroon, the Dominican Republic, Kenya, Moldova, the Philippines, Suriname, and Tunisia.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.